C-2 MODIFIED ERYTHROMYCIN DERIVATIVES

A compound having the formula selected from the group consisting of a compound of formula (I), a compound of formula (II), and a compound of formula (III) as well as pharmaceutically acceptable salts, esters, solvates, metabolites, and prodrugs thereof, are useful in treating bacterial infections. A...

Full description

Saved in:
Bibliographic Details
Main Author SUOMING, ZHANG
Format Patent
LanguageEnglish
Spanish
Published 30.07.2002
Edition7
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

More Information
Summary:A compound having the formula selected from the group consisting of a compound of formula (I), a compound of formula (II), and a compound of formula (III) as well as pharmaceutically acceptable salts, esters, solvates, metabolites, and prodrugs thereof, are useful in treating bacterial infections. Also provided are pharmaceutically acceptable compositions, methods of treating bacterial infections, and processes for the preparation of the compounds. Se describe un compuesto que tiene la formula seleccionada del grupo que consiste de un compuesto de la formula (I), un compuesto de la formula (II) y un compuesto de la formula (III) asi como sales farmaceuticamente aceptables, esteres, solvatos, metabolitos y sus profarmacos, utiles para el tratamiento de infecciones bacterianas. Tambien se proporcionan composiciones farmaceuticamente aceptables, metodos para tratar infecciones bacterianas, y procedimientos para la preparacion de los compuestos. (Ver Formula).
Bibliography:Application Number: MX2001PA11633